Here are four notes:
1. Mizuho has a $71.00 price target on AmSurg shares.
2. The firm’s target price suggests a 5.48 percent potential upside from AmSurg’s previous closing.
3. On Nov. 2, 2016, Wells Fargo & Co. rated AmSurg shares an “outperform” rating.
4. During the third quarter of fiscal year 2016, AmSurg had $1.13 earnings per share.
More articles on surgery centers:
Methodist Center for Diagnostic Imaging opens with 1st high-field open MRI in Dallas: 4 key notes
BayCare Health System considers building new outpatient facility — 4 notes
Christ Hospital Health Network still awaiting CON approval for $24M ASC — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.